Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Arguedas en familia : cartas de José María Arguedas a Arístides y Nelly Arguedas, a Rosa Pozo Navarro y Yolanda López Pozo

View through CrossRef
Se publican aquí cerca de 80 cartas que José María Arguedas dirige a sus familiares más cercanos: a su hermano mayor Arístides Arguedas Altamirano, a su hermana menor Nelly Arguedas, a su tía Rosa Pozo Navarro y a su prima Yolanda López Pozo de Ochoa.
Pontificia Universidad Católica del Perú
Title: Arguedas en familia : cartas de José María Arguedas a Arístides y Nelly Arguedas, a Rosa Pozo Navarro y Yolanda López Pozo
Description:
Se publican aquí cerca de 80 cartas que José María Arguedas dirige a sus familiares más cercanos: a su hermano mayor Arístides Arguedas Altamirano, a su hermana menor Nelly Arguedas, a su tía Rosa Pozo Navarro y a su prima Yolanda López Pozo de Ochoa.

Related Results

Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal
Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal
Abstract The fundamental value of universal nomenclatural systems in biology is that they enable unambiguous scientific communication. However, the stability of thes...
The Andean Visual Poetics of José María Arguedas
The Andean Visual Poetics of José María Arguedas
<b>José María Arguedas (1911-1969) was one of the most notable Peruvian writers of the 20th century. He was a prose writer, poet, anthropologist and translator who wrote in b...
The Andean Visual Poetics of José María Arguedas
The Andean Visual Poetics of José María Arguedas
<b>José María Arguedas (1911-1969) was one of the most notable Peruvian writers of the 20th century. He was a prose writer, poet, anthropologist and translator who wrote in b...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Evaluation of Rosa Species Accessions for Resistance to Eriophyid Mites1
Evaluation of Rosa Species Accessions for Resistance to Eriophyid Mites1
Abstract Rose rosette disease, caused by rose rosette virus (RRV), is an epidemic affecting nearly every rose cultivar in the United States. The only hosts for Phyllocoptes...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...

Back to Top